Predilife (ALPRE) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.219x

Based on the latest financial reports, Predilife (ALPRE) has a cash flow conversion efficiency ratio of 0.219x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.28 Million ≈ $-1.49 Million USD) by net assets (€-5.82 Million ≈ $-6.80 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Predilife net asset quality index to measure how much of total assets are equity-financed.

Predilife - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Predilife's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Predilife (ALPRE) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Predilife Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Predilife ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bank Danamon Indonesia Tbk JK:BDMN	0.052x
TOP Ships Inc. NYSE MKT:TOPS	0.081x
BRITANNIA LIFE SCIENCES F:L020	0.057x
ConnectM Technology Solutions, Inc. NASDAQ:CNTM	0.098x
Anglo Asian Mining Plc LSE:AAZ	0.159x
Wickes Group PLC LSE:WIX	1.293x
Cahaya Bintang Medan Tbk Pt JK:CBMF	0.000x
Brilliant Future AB ST:BRILL	-0.207x

Annual Cash Flow Conversion Efficiency for Predilife (2016–2024)

The table below shows the annual cash flow conversion efficiency of Predilife from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Predilife market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-4.27 Million ≈ $-4.99 Million	€-3.72 Million ≈ $-4.35 Million	0.872x	+110.59%
2023-12-31	€513.52K ≈ $600.36K	€-4.23 Million ≈ $-4.94 Million	-8.236x	-1502.63%
2022-12-31	€-5.22 Million ≈ $-6.10 Million	€-3.07 Million ≈ $-3.58 Million	0.587x	-75.98%
2021-12-31	€-1.57 Million ≈ $-1.83 Million	€-3.83 Million ≈ $-4.47 Million	2.445x	+183.67%
2020-12-31	€721.69K ≈ $843.73K	€-2.11 Million ≈ $-2.47 Million	-2.922x	-193.26%
2019-12-31	€-764.29K ≈ $-893.53K	€-2.39 Million ≈ $-2.80 Million	3.133x	-97.90%
2018-12-31	€-12.10K ≈ $-14.15K	€-1.81 Million ≈ $-2.11 Million	149.479x	+12560.50%
2017-12-31	€-1.29 Million ≈ $-1.51 Million	€-1.53 Million ≈ $-1.78 Million	1.181x	+131.59%
2016-12-31	€362.63K ≈ $423.95K	€-1.36 Million ≈ $-1.58 Million	-3.737x	--

About Predilife

PA:ALPRE France Diagnostics & Research

Market Cap

$5.50 Million

€4.70 Million EUR

Market Cap Rank

#28362 Global

#512 in France

Share Price

€1.20

Change (1 day)

+0.00%

52-Week Range

€0.95 - €3.54

All Time High

€15.90